Hansoh Pharmaceutical (Aumolertinib License) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Hansoh Pharmaceutical (Aumolertinib License) General Information
Description
Aumolertinib license assets based in China. The license consists for research, development and commercialization of aumolertinib.
Contact Information
Corporate Office
- China
Corporate Office
- China
Hansoh Pharmaceutical (Aumolertinib License) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hansoh Pharmaceutical (Aumolertinib License) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hansoh Pharmaceutical (Aumolertinib License) FAQs
-
Where is Hansoh Pharmaceutical (Aumolertinib License) headquartered?
Hansoh Pharmaceutical (Aumolertinib License) is headquartered in China.
-
What industry is Hansoh Pharmaceutical (Aumolertinib License) in?
Hansoh Pharmaceutical (Aumolertinib License)’s primary industry is Buildings and Property.
-
Is Hansoh Pharmaceutical (Aumolertinib License) a private or public company?
Hansoh Pharmaceutical (Aumolertinib License) is a Private company.
-
What is Hansoh Pharmaceutical (Aumolertinib License)’s current revenue?
The current revenue for Hansoh Pharmaceutical (Aumolertinib License) is .
-
Who are Hansoh Pharmaceutical (Aumolertinib License)’s investors?
Hansoh Pharma has invested in Hansoh Pharmaceutical (Aumolertinib License).
-
When was Hansoh Pharmaceutical (Aumolertinib License) acquired?
Hansoh Pharmaceutical (Aumolertinib License) was acquired on 22-Jul-2020.
-
Who acquired Hansoh Pharmaceutical (Aumolertinib License)?
Hansoh Pharmaceutical (Aumolertinib License) was acquired by EQRx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process